
VivioMD Review
GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: flat-priced GLP-1 care with a refund if you are not approved
VivioMD scores highest on state availability and ease of access.
What the plan covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
VivioMD is a telehealth weight-management service that does sell GLP-1 treatment, but publishes no price on any public page. Its homepage promises flat pricing that never goes up as your dose increases, a full refund if you are not approved, cancellation with no fees, and HSA/FSA eligibility, with clinicians from OpenLoop Healthcare Partners P.C. and medication from independent state-licensed pharmacies. It names no medication anywhere, offering only 'top GLP-1 treatments — brand-name and personalized options'.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to VivioMD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
VivioMD at a glance
- Type
- GLP-1 telehealth provider
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- 1 FDA warning letter on record; see below
How we scored VivioMD
Each dimension is scored algorithmically from VivioMD'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.0/10VivioMD does not post a standard monthly cash price up front, so cost transparency is limited. Confirm the ongoing rate before you commit.
Effectiveness25%
6.2/10VivioMD does not name the medications its program uses, so there is no published medication lineup to assess. Ask which drug you would be prescribed before you start.
User Experience15%
7.8/10Online intake and platform experience (consult included in the price); 0 platform features disclosed.
Trust & Safety15%
6.8/10Key details fully confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).
Accessibility10%
9.0/10VivioMD treats patients in all 50 states.
Support10%
6.6/10VivioMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this VivioMD review
Last checked November 2026- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with VivioMD
We walked VivioMD's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health assessment.
- 2A licensed provider reviews your evaluation (an online evaluation; no video visit stated).
- 3If approved, medication is delivered to your door.
- The public site names no medication at all (only 'top GLP-1 treatments'), and the intake asks injection or dissolvable tablet without naming a drug.
- Described as an 'online evaluation'; no video visit explicitly required.
- Discloses compounded meds are not FDA-approved.
- No monthly price is displayed on the homepage, no pricing page exists, and 24 intake screens show no figure either.
- Clinicians are named as OpenLoop Healthcare Partners P.C., and the pharmacies only as 'independent, state-licensed U.S. compounding and retail pharmacies'.
VivioMD customer support
- Phone
- (678) 258-9290
- Hours
- 24/7 messaging with care team
What we like
- Flat pricing: the site says the cost never goes up as your dose increases
- Full refund if you are not approved, and cancellation with no fees
- HSA and FSA eligible, with clinicians named as OpenLoop Healthcare Partners P.C.
- Licensed providers claimed in all 50 states
Watch-outs
- Publishes no price on any public page, and two dozen intake screens show none either
- Names no medication anywhere; the site offers only 'top GLP-1 treatments'
- Dispensing pharmacies are described only as 'independent, state-licensed' and are never named
- Received an FDA warning letter in June 2026 over false or misleading claims about compounded GLP-1 products
VivioMD: a 50-state telehealth program that won't show you a price
VivioMD is a nationwide telehealth wellness service that markets a physician-supervised weight program with the medication, the provider consult, and shipping all rolled into one plan. The pitch is simplicity: board-certified, U.S.-licensed clinicians who can see patients in all 50 states, with treatment mailed to your door. That broad licensing footprint is useful if you live somewhere most compounding-focused telehealth brands skip. But VivioMD publishes no price anywhere on its public site, so know that before you sign up.
Where the price is, and where it isn't
VivioMD's homepage sells the program hard (a summer promotion banner of a hundred dollars off plus free shipping, “Flat pricing — never goes up as your dose increases,” a five-minute assessment), but it never prints a monthly figure, and there is no pricing page. The number appears only inside the sign-up flow, after a long run of health questions. Confirm the exact plan, drug, and monthly cost inside VivioMD's intake before you pay.
How the pricing model works
VivioMD uses an all-inclusive monthly structure rather than charging separately for the visit, the prescription, and delivery. The medication, a live provider consult, and free shipping are bundled into the plan price, so the number you see is meant to be the number you pay, with no surprise consult fee stacked on top. That bundling is a plus for budgeting, because it removes the membership-plus-pharmacy math that trips people up elsewhere.
VivioMD also promises the price will not rise as your dose does, that HSA and FSA cards are accepted, that you can cancel anytime with no fees, and that you get a full refund if a provider does not approve you. Those are useful terms, but without a published figure you can't weigh them against anyone else's until you're most of the way through the intake. For comparison, the category median across the providers we track is $179 a month. See our scoring methodology for how we weigh price against everything else.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
Medications and how they're dispensed
The public site names no medication. It offers “top GLP-1 treatments — brand-name and personalized options,” and its footer lists Wegovy, Ozempic, Mounjaro, and Zepbound only as trademarks it is not affiliated with, alongside a note that a provider may prescribe a compounded medication. So before the intake you will not know if the offer is compounded semaglutide, compounded tirzepatide, or a brand pen. About two dozen screens into the intake, the quiz asks whether you'd rather take a weekly injection or a daily dissolvable tablet, and whether you care more about price or potency, still without naming a drug or a dollar figure. MEDVi shows its compounded injection and tablet prices before you start, alongside brand-name Wegovy and Zepbound. Prescribing is done by clinicians from OpenLoop Healthcare Partners P.C., and medication ships from independent, state-licensed compounding and retail pharmacies with delivery included.
One caution: compounded GLP-1 medicines are not FDA-approved products; they're prepared by compounding pharmacies and aren't reviewed the way brand drugs are. VivioMD does not publish the specific compounding pharmacy or its accreditation. Lean Meds uses the same OpenLoop medical group. It names its four dispensing pharmacies, with addresses. If pharmacy sourcing matters to you (and for an injectable it should), ask VivioMD which pharmacy fills your prescription and whether it's state-licensed and accredited before your first shipment.
Reach and an all-in-one plan
VivioMD's first strength is reach. It leans hard on its claim of licensed providers in all 50 states, and plenty of telehealth weight programs exclude a handful of states, leaving patients in those gaps stuck. If you've been turned away elsewhere because of where you live, a provider built around nationwide coverage is one to consider.
The second is the all-in-one experience: one price, a live provider consult attached to every plan, free shipping, and 24/7 messaging with a care team. Add the refund-if-not-approved promise and there is little financial risk in finding out what the price is.
Who should choose it
- You live in a state where other telehealth GLP-1 programs won't prescribe and you need broad licensing
- You want one bundled monthly price with the consult and shipping included, not itemized add-ons
- You'd rather answer the health questions first and see the price afterward than the other way around
- You'd consider brand-name Ozempic and accept its much higher list price; if a brand pen is the plan from the start, Push Health routes Ozempic, Zepbound and Mounjaro prescriptions through a large pharmacy network, though it publishes little about pricing
Who should skip it
- You want to see a price before you answer health questions, since VivioMD shows one only inside the intake
- You need full transparency on the compounding pharmacy and its accreditation up front
- You want to know which molecule you'll be offered before you start (the public site names none)
- You'd rather use a provider the FDA has never written to; VivioMD drew a warning letter in June 2026
Trust, safety, and medical oversight
FDA sent VivioMD Group LLC a warning letter in June 2026, headed false and misleading claims / misbranded, over the compounded semaglutide and tirzepatide it sells; the full notice is further down this page. On the positive side, the program is physician-supervised with a live consult built into every plan, and the footer links to a LegitScript check. The weak spot is transparency: no named compounding partner, no published medication list, and no published price. None of that means VivioMD is unsafe; it means you should confirm more inside the intake than you would with a fully transparent provider.
Bottom line
VivioMD offers nationwide licensing, an all-inclusive bundle, a flat-price promise, and a refund if you aren't approved. But it tells you nothing about price or medication until you're deep in its intake, and it carries a June 2026 FDA letter. If broad state coverage is what you need, the five-minute assessment is a short way to find out more. Just confirm the price, the exact medication, and the filling pharmacy inside VivioMD's flow before you commit.
The Bottom Line
VivioMD scores highest on state availability and ease of access.
Ready to start with VivioMD?
See current pricing and start your online intake.
VivioMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
VivioMD received an FDA warning letter dated June 8, 2026
The letter concerns false and misleading claims and misbranded drugs (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this VivioMD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See VivioMD's current pricing
Start the online intake to check eligibility and today's price.